ArticleBriefings in bioinformatics2024
AIGen: an artificial intelligence software for complex genetic data analysis.
Article in Briefings in bioinformatics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The recent development of artificial intelligence (AI) technology, especially the advance of deep neural network (DNN) technology, has revolutionized many fields. While DNN plays a central role in modern AI technology, it has rarely been used in genetic data analysis due to analytical and computational challenges brought by high-dimensional genetic data and an increasing number of samples. To facilitate the use of AI in genetic data analysis, we developed a C++ package, AIGen, based on two newly developed neural networks (i.e. kernel neural networks and functional neural networks) that are capable of modeling complex genotype-phenotype relationships (e.g. interactions) while providing robust performance against high-dimensional genetic data. Moreover, computationally efficient algorithms (e.g. a minimum norm quadratic unbiased estimation approach and batch training) are implemented in the package to accelerate the computation, making them computationally efficient for analyzing large-scale datasets with thousands or even millions of samples. By applying AIGen to the UK Biobank dataset, we demonstrate that it can efficiently analyze large-scale genetic data, attain improved accuracy, and maintain robust performance. Availability: AIGen is developed in C++ and its source code, along with reference libraries, is publicly accessible on GitHub at https://github.com/TingtHou/AIGen.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.